Singapore biotech firm JN Medsys develops a PCR test kit tha

Singapore biotech firm JN Medsys develops a PCR test kit that specifically detects for the Omicron variant with high accuracy

SINGAPORE, Jan. 12, 2022 /PRNewswire/ -- Singapore-based biotech firm, JN Medsys announces that it has developed a new PCR kit that detects for SARS-CoV-2 and identifies if the Omicron variant

Related Keywords

South Africa , Singapore , Kostenloser Wertpapierhandel , Gwen Xie , Singapore Health Sciences Authority , World Health Organization , Protect Omivar , Health Sciences Authority , Biotech , Firm , Edsys , Evelops , Pest , Specifically , Detects , Micron , Variant , Thigh , Accuracy ,